Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	75
Overall Study	STARTED	Alogliptin 6.25 mg QD	79
Overall Study	STARTED	Alogliptin 12.5 mg QD	84
Overall Study	STARTED	Alogliptin 25 mg QD	80
Overall Study	STARTED	Alogliptin 50 mg QD	79
Overall Study	STARTED	Voglibose 0.2 mg TID	83
Overall Study	COMPLETED	Placebo	73
Overall Study	COMPLETED	Alogliptin 6.25 mg QD	74
Overall Study	COMPLETED	Alogliptin 12.5 mg QD	80
Overall Study	COMPLETED	Alogliptin 25 mg QD	77
Overall Study	COMPLETED	Alogliptin 50 mg QD	76
Overall Study	COMPLETED	Voglibose 0.2 mg TID	78
Overall Study	NOT COMPLETED	Placebo	2
Overall Study	NOT COMPLETED	Alogliptin 6.25 mg QD	5
Overall Study	NOT COMPLETED	Alogliptin 12.5 mg QD	4
Overall Study	NOT COMPLETED	Alogliptin 25 mg QD	3
Overall Study	NOT COMPLETED	Alogliptin 50 mg QD	3
Overall Study	NOT COMPLETED	Voglibose 0.2 mg TID	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01263470/flow